OpenSAFELY Vaccine Coverage Report

AstraZeneca / Priority Group 3

Data from combined, up to 2021-03-07.

Vaccinated at 2021-03-07 (%) Vaccinated at 2021-03-07 (n) Population Vaccinated at 2021-02-28 (%) Vaccinated in past week (%)
Overall - 48.4% 951,860 1,966,076 48.1% 0.3%
Sex Female 48.5% 508,095 1,047,270 48.2% 0.3%
Male 48.3% 443,765 918,806 48.0% 0.3%
Ethnicity White - British 49.5% 595,595 1,204,427 49.2% 0.2%
White - Irish 42.7% 7,105 16,639 42.3% 0.4%
White - Any other White background 39.0% 16,835 43,148 38.6% 0.5%
Mixed - White and Black Caribbean 38.9% 833 2,142 37.6% 1.3%
Mixed - White and Black African 35.8% 406 1,134 35.2% 0.6%
Mixed - White and Asian 39.8% 518 1,302 38.7% 1.1%
Mixed - Any other mixed background 38.8% 882 2,275 38.2% 0.6%
Asian or Asian British - Indian 39.1% 9,961 25,501 38.6% 0.4%
Asian or Asian British - Pakistani 38.7% 4,095 10,570 37.4% 1.4%
Asian or Asian British - Bangladeshi 40.8% 1,190 2,919 38.8% 1.9%
Asian or Asian British - Any other Asian background 36.5% 4,165 11,410 36.0% 0.6%
Black or Black British - Caribbean 34.5% 3,934 11,410 33.1% 1.3%
Black or Black British - African 29.8% 2,387 8,015 28.2% 1.6%
Black or Black British - Any other Black background 34.0% 595 1,750 33.2% 0.8%
Other ethnic groups - Chinese 36.2% 1,148 3,171 35.5% 0.7%
Other ethnic groups - Any other ethnic group 39.1% 2,492 6,370 38.2% 0.9%
Patients with any other ethnicity code 48.9% 135,107 276,143 48.7% 0.3%
Ethnicity not stated 47.9% 5,628 11,739 47.6% 0.4%
Ethnicity not recorded 48.8% 158,893 325,899 48.4% 0.3%
Ethnicity (broad categories) White 49.0% 619,549 1,264,228 48.8% 0.3%
Mixed 38.6% 2,653 6,874 37.9% 0.7%
South Asian 38.5% 19,425 50,414 37.8% 0.7%
Black 32.7% 6,930 21,189 31.3% 1.4%
Other 38.1% 3,640 9,548 37.4% 0.7%
Unknown 48.8% 299,642 613,795 48.5% 0.3%
Index of Multiple Deprivation 1 (most deprived) 47.2% 273,833 580,468 46.8% 0.4%
2 47.1% 126,560 268,884 46.7% 0.4%
3 49.0% 167,622 341,789 48.8% 0.3%
4 49.3% 183,960 373,303 49.1% 0.2%
5 (least deprived) 49.7% 191,940 386,337 49.5% 0.2%
Unknown 51.8% 7,917 15,274 51.5% 0.4%
Clinical Risk Groups Patients in Any Clinical Risk Group 49.1% 567,357 1,156,127 48.7% 0.3%
Patients with Immunosuppression 48.9% 41,685 85,309 48.5% 0.3%
Patients with CKD 49.3% 158,116 321,027 48.9% 0.3%
Patients who have Chronic Respiratory Disease 49.9% 111,699 223,678 49.5% 0.4%
Patients with Diabetes 48.7% 178,290 366,072 48.3% 0.4%
Patients with Chronic Liver disease 48.2% 25,060 51,954 47.9% 0.4%
Patients with CNS Disease (including Stroke/TIA) 51.3% 108,675 211,911 50.9% 0.4%
Patients with Chronic heart disease 49.4% 290,976 588,749 49.1% 0.3%
Patients with Asplenia or Dysfunction of the Spleen 49.2% 8,414 17,108 48.8% 0.4%
Patients with Wider Learning Disability 56.2% 1,309 2,331 54.7% 1.5%
Patients with Severe Mental Health 50.6% 7,966 15,750 49.7% 0.8%
Other Groups Patients who are shielding (High Risk from COVID-19) 49.3% 151,263 306,628 48.8% 0.5%
Patients with Morbid Obesity 51.2% 24,423 47,663 50.7% 0.5%
Patients who are pregnant 48.5% 112 231 48.5% 0.0%